Product news

Share this article:

Xanodyne Pharmaceuticals has received an approvable letter from the FDA for Zipsor, indicated for mild to moderate acute pain. Zipsor is an immediate release liquid-filled soft gelatin capsule containing 25 mg of diclofenac potassium, for oral administration.   

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters